Literature DB >> 18657721

Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.

Niklaus H Mueller1, Donald H Gilden, Randall J Cohrs, Ravi Mahalingam, Maria A Nagel.   

Abstract

Varicella zoster virus (VZV) is an exclusively human neurotropic alphaherpesvirus. Primary infection causes varicella (chickenpox), after which virus becomes latent in cranial nerve ganglia, dorsal root ganglia, and autonomic ganglia along the entire neuraxis. Years later, in association with a decline in cell-mediated immunity in elderly and immunocompromised individuals, VZV reactivates and causes a wide range of neurologic disease. This article discusses the clinical manifestations, treatment, and prevention of VZV infection and reactivation; pathogenesis of VZV infection; and current research focusing on VZV latency, reactivation, and animal models.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657721      PMCID: PMC2754837          DOI: 10.1016/j.ncl.2008.03.011

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  183 in total

1.  Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity.

Authors:  U Heininger; C Braun-Fahrländer; D Desgrandchamps; J Glaus; L Grize; P Wutzler; U B Schaad
Journal:  Pediatr Infect Dis J       Date:  2001-08       Impact factor: 2.129

2.  Pilot tolerability and effectiveness study of levetiracetam for postherpetic neuralgia.

Authors:  Michael C Rowbotham; Nira S Manville; Junlong Ren
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

3.  Varicella zoster virus cerebellitis in a 66-year-old patient without herpes zoster.

Authors:  Peter Ratzka; Johannes C M Schlachetzki; Mathias Bähr; Roland Nau
Journal:  Lancet       Date:  2006-01-14       Impact factor: 79.321

4.  [Myelitis and optic neuritis caused by varicella].

Authors:  M A Pina; J R Ara; J L Capablo; M Omeñaca
Journal:  Rev Neurol       Date:  1997-10       Impact factor: 0.870

5.  Detecting varicella-zoster virus DNA in iridocyclitis using polymerase chain reaction: a case of zoster sine herpete.

Authors:  S Yamamoto; R Tada; Y Shimomura; D Pavan-Langston; E C Dunkel; Y Tano
Journal:  Arch Ophthalmol       Date:  1995-11

Review 6.  Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS.

Authors:  Carlos Franco-Paredes; Thomas Bellehemeur; Ali Merchant; Pramod Sanghi; Carlos DiazGranados; David Rimland
Journal:  AIDS       Date:  2002-05-03       Impact factor: 4.177

7.  Distribution of latent herpes simplex virus type-1 and varicella zoster virus DNA in human trigeminal Ganglia.

Authors:  Randall J Cohrs; James J Laguardia; Donald Gilden
Journal:  Virus Genes       Date:  2005-10       Impact factor: 2.332

8.  Bromovinyldeoxyurdine treatment of outer retinal necrosis due to varicella-zoster virus: a case-report.

Authors:  H Dullaert; P C Maudgal; A Leys; L Dralands; E Clercq
Journal:  Bull Soc Belge Ophtalmol       Date:  1996

Review 9.  Effectiveness of live varicella vaccine.

Authors:  Michiaki Takahashi
Journal:  Expert Opin Biol Ther       Date:  2004-02       Impact factor: 4.388

10.  The value of cerebrospinal fluid antiviral antibody in the diagnosis of neurologic disease produced by varicella zoster virus.

Authors:  D H Gilden; J L Bennett; B K Kleinschmidt-DeMasters; D D Song; A S Yee; I Steiner
Journal:  J Neurol Sci       Date:  1998-08-14       Impact factor: 3.181

View more
  87 in total

1.  Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells.

Authors:  Jenna Christensen; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3.

Authors:  Huifang Zhu; Chunfu Zheng; Junji Xing; Shuai Wang; Shuping Li; Rongtuan Lin; Karen L Mossman
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

3.  Presentation and management of herpes zoster (shingles) in the geriatric population.

Authors:  Kenneth R Cohen; Rebecca L Salbu; Jerry Frank; Igor Israel
Journal:  P T       Date:  2013-04

4.  Multifocal strokes in a 56-year-old man with HIV infection.

Authors:  Ariel Lefkowitz; Wayne L Gold; Leanne K Casaubon; Daniel M Mandell; Jeffrey Craig
Journal:  CMAJ       Date:  2015-05-25       Impact factor: 8.262

5.  Altered CD4+ T cell immunity in nurses occupationally exposed to viral pathogens.

Authors:  G Elias; A Souquette; S Heynderickx; I De Meester; H Jansens; P Beutels; P Van Damme; E Smits; P G Thomas; V Van Tendeloo; B Ogunjimi
Journal:  Clin Exp Immunol       Date:  2018-09-19       Impact factor: 4.330

6.  Pseudorabies virus infection alters neuronal activity and connectivity in vitro.

Authors:  Kelly M McCarthy; David W Tank; Lynn W Enquist
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

Review 7.  Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.

Authors:  Tobias R Kollmann; Ofer Levy; Ruth R Montgomery; Stanislas Goriely
Journal:  Immunity       Date:  2012-11-16       Impact factor: 31.745

8.  Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.

Authors:  Lianjuan Yang; Xiaohui Mo; Hong Yang; Hejun Dai; Fei Tan
Journal:  J Mol Model       Date:  2014-06-25       Impact factor: 1.810

Review 9.  HIV interactions with monocytes and dendritic cells: viral latency and reservoirs.

Authors:  Christopher M Coleman; Li Wu
Journal:  Retrovirology       Date:  2009-06-01       Impact factor: 4.602

10.  A 46-year-old female presenting with worsening headache, nuchal rigidity and a skin rash in varicella zoster virus meningitis: a case report.

Authors:  Anurag Kushawaha; Neville Mobarakai; Jill Tolia
Journal:  Cases J       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.